TRIM56 Reduces Radiosensitization of Human Glioblastoma by Regulating FOXM1-Mediated DNA Repair

Purine metabolism regulates DNA repair and therapy resistance in glioblastoma

(2020) Weihua Zhou et al.   Nature Communications

UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation

(2020) Jingyuan Sun et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol

(2019) Paul Lesueur et al.   BMC CANCER

Targeted Therapies for the Treatment of Glioblastoma in Adults

(2019) Ding Fang Chuang et al.   Current Oncology Reports

The role of TRIM family proteins in the regulation of cancer stem cell self-renewal: Concise review

(2019) Anna Maria Jaworska et al.   STEM CELLS

Radiation-Induced Changes in Tumor Vessels and Microenvironment Contribute to Therapeutic Resistance in Glioblastoma

(2019) Yun-Soo Seo et al.   Frontiers in Oncology

Systematic analysis of gene expression profiles reveals prognostic stratification and underlying mechanisms for muscle-invasive bladder cancer

(2019) Ping-Bao Zhang et al.   Cancer Cell International

Corosolic acid induces cell cycle arrest and cell apoptosis in human retinoblastoma Y-79 cells via disruption of MELK-FoxM1 signaling

(2018) Ke Wang et al.   ONCOLOGY REPORTS

FoxM1-dependent RAD51 and BRCA2 signaling protects idiopathic pulmonary fibrosis fibroblasts from radiation-induced cell death

(2018) Jintaek Im et al.   Cell Death & Disease

FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma

(2018) Chunli Zhang et al.   Cell Death & Disease

Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells

(2018) Jacinth Rajendra et al.   Oncotarget

UBE2C Is a Transcriptional Target of the Cell Cycle Regulator FOXM1

(2018) Pedro Nicolau-Neto et al.   Genes

Regulation of the master regulator FOXM1 in cancer

(2018) Guo-Bin Liao et al.   Cell Communication and Signaling

Expression of the human TRIM14 and its mutant form (P207L) promotes apoptosis in transgenic loaches

(2018) Valentina V. Nenasheva et al.   MOLECULAR BIOLOGY REPORTS

Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance

(2018) Evan K. Noch et al.   World Neurosurgery

Poly r(C) Binding Protein 1 Regulates Posttranscriptional Expression of the Ubiquitin Ligase TRIM56 in Ovarian Cancer

(2018) Lei Zhao et al.   IUBMB LIFE

Association of patterns of care, prognostic factors, and use of radiotherapy–temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study

(2018) Pascale Fabbro-Peray et al.   JOURNAL OF NEURO-ONCOLOGY

The ubiquitin ligase TRIM56 inhibits ovarian cancer progression by targeting vimentin

(2017) Lei Zhao et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma

(2017) Xue Zhang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Roles of FoxM1 in cell regulation and breast cancer targeting therapy

(2017) Xin Song et al.   MEDICAL ONCOLOGY

The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma

(2017) Qing Ma et al.   ONCOLOGY REPORTS

FoxM1: Repurposing an oncogene as a biomarker

(2017) Deeptashree Nandi et al.   SEMINARS IN CANCER BIOLOGY

TRIM Family Proteins: Roles in Autophagy, Immunity, and Carcinogenesis

(2017) Shigetsugu Hatakeyama   TRENDS IN BIOCHEMICAL SCIENCES

Structural basis for the recognition and degradation of host TRIM proteins by Salmonella effector SopA

(2017) Evgenij Fiskin et al.   Nature Communications

Inhibition of FoxM1-Mediated DNA Repair by Imipramine Blue Suppresses Breast Cancer Growth and Metastasis

(2016) S. Rajamanickam et al.   CLINICAL CANCER RESEARCH

A novel FOXM1 isoform, FOXM1D, promotes epithelial–mesenchymal transition and metastasis through ROCKs activation in colorectal cancer

(2016) X Zhang et al.   ONCOGENE

FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways

(2016) Fergal C. Kelleher et al.   Oncotarget

RNF168 cooperates with RNF8 to mediate FOXM1 ubiquitination and degradation in breast cancer epirubicin treatment

(2016) M Kongsema et al.   Oncogenesis

OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance

(2015) U Karunarathna et al.   ONCOGENE

TRIM Proteins Regulate Autophagy and Can Target Autophagic Substrates by Direct Recognition

(2014) Michael A. Mandell et al.   DEVELOPMENTAL CELL

The Ubiquitin Code

(2012) David Komander et al.   Annual Review of Biochemistry

FoxM1 Inhibition Sensitizes Resistant Glioblastoma Cells to Temozolomide by Downregulating the Expression of DNA-Repair Gene Rad51

(2012) N. Zhang et al.   CLINICAL CANCER RESEARCH

Glioblastoma research 2006–2010: Pattern of citation and systematic review of highly cited articles

(2012) Carsten Nieder et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Location, Location, Location: FoxM1 Mediates β-Catenin Nuclear Translocation and Promotes Glioma Tumorigenesis

(2011) Angela Bowman et al.   CANCER CELL

Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells

(2011) S. C. Short et al.   NEURO-ONCOLOGY

TRIM Proteins: Another Class of Viral Victims

(2010) M. Munir   Science Signaling

The emerging complexity of protein ubiquitination

(2009) David Komander   BIOCHEMICAL SOCIETY TRANSACTIONS

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY